Blog
RSS FeedPosted by Michael Wonder on 30 Jul 2024
HLS announces reimbursement for Vascepa under Alberta's Provincial Drug Plan
29 July 2024 - With the addition of Alberta's public plan, Vascepa will be available to more than 90% of ...
Posted by Michael Wonder on 03 May 2022
Boehringer Ingelheim Canada announces reimbursement for Ofev (nintedanib) in seven public drug plans for the treatment of progressive fibrosing interstitial lung diseases
3 May 2022 - Boehringer Ingelheim is pleased to announce that Ofev (nintedanib), is now available for public reimbursement in Quebec, ...
Posted by Michael Wonder on 30 Jan 2022
Baqsimi (nasal glucagon) rescue treatment for severe hypoglycaemia now covered in Ontario
28 January 2022 - Lilly Canada is pleased to announce that as of 31 January 2022, Baqsimi (glucagon nasal powder) ...
Posted by Michael Wonder on 14 Feb 2020
AbbVie's Skyrizi now listed on the Nova Scotia formulary for the treatment of moderate to severe plaque psoriasis
13 February 2020 - Nova Scotia lists Skyrizi on its provincial formulary effective February 06, 2020. ...
Posted by Michael Wonder on 07 Feb 2020
AbbVie's Skyrizi now publicly reimbursed in Ontario, Alberta, Saskatchewan and Quebec for the treatment of moderate to severe plaque psoriasis
6 February 2020 - Skyrizi is the only IL-23 inhibitor to arrive at a positive conclusion with the pCPA and is ...
Posted by Michael Wonder on 22 Sep 2018
Ontario becomes first province to provide public funding of Tresiba for adults with diabetes mellitus
21 September 2018 - Manitoba to reimburse Tresiba following Ontario listing. ...
Posted by Michael Wonder on 30 Aug 2018
Renflexis (infliximab for injection) added to British Columbia's Provincial Drug Plan for all approved indications
22 August 2018 - Renflexis has been added to drug formulary for the treatment of adult and paediatric Crohn's disease and ...
Posted by Michael Wonder on 19 Apr 2018
Four Canadian provinces add Erelzi (etanercept) to provincial drug plans for the treatment of multiple inflammatory diseases
19 April 2018 - Erelzi has been added to drug formularies in Manitoba, Saskatchewan, Alberta and Newfoundland based on specific criteria ...
Posted by Michael Wonder on 06 Feb 2018
Quebec adds Erelzi (etanercept) to provincial drug plans for the treatment of multiple inflammatory diseases
5 February 2018 - Erelzi has been added to the Quebec Drug Insurance Plan based on specific criteria for the treatment ...
Posted by Michael Wonder on 05 Feb 2018
Acerus Pharma’s Natesto to be listed for public reimbursement in Quebec
1 February 2018 - Acerus Pharmaceuticals Corporation today announced that it has received notice from Quebec’s National Institute for Excellence ...
Posted by Michael Wonder on 10 Jan 2018
Ontario has added Erelzi (etanercept) to public drug plan for the treatment of multiple inflammatory diseases
9 January 2018 - Erelzi has been added to public drug plan based on specific criteria in Ontario for the treatment ...
Posted by Michael Wonder on 16 Nov 2017
British Columbia and Prince Edward Island become the first provinces to add Erelzi (etanercept) to public drug plans for the treatment of multiple inflammatory diseases
16 November 2017 - Erelzi also becomes the first biosimilar indicated for polyarticular juvenile idiopathic arthritis under these provincial public drug ...
Posted by Michael Wonder on 10 May 2017
Novartis heart failure treatment Entresto (sacubitril/valsartan) now available to patients in Ontario through the public provincial drug plan
9 May 2017 - Entresto has been shown to reduce the risk of cardiovascular death and hospitalization in heart failure ...
Posted by Michael Wonder on 10 May 2017
Provincial drug plans, including Ontario and BC, make Entyvio (vedolizumab) available to treat inflammatory bowel disease
9 May 2017 - Gut-selective treatment now funded publicly for Canadians with ulcerative colitis and Crohn's disease. ...
Posted by Michael Wonder on 26 Aug 2016
New Brunswick includes Lemtrada (alemtuzumab) on provincial drug program for eligible patients
25 August 2016 - Unique treatment delivered in only two cycles one year apart. ...